On 26 August 2026, IFPMA delivered a statement on a strategy for financing the future of health in the WHO African Region, 2026-2036, during the 76th WHO Regional Committee for Africa in Addis Ababa, Ethiopia.

IFPMA welcomes the strategy for financing the future of health in the WHO African Region and its focus on sustainable, efficient, and inclusive financing systems to advance Universal Health Coverage, financial protection, and improved access to quality care.

We strongly support its objectives to strengthen national health financing systems, improve equitable and efficient resource use, reduce out-of-pocket spending, reinforce governance and accountability, and integrate health financing into national and regional development agendas.

We welcome the emphasis on accountability and stronger health financing capacity to support evidence-based decision-making and strategic purchasing. Stronger coordination between ministries of health and finance, anchored in joint planning, is essential to align funding with national priorities, improve efficiency, and maximize the impact of available resources.

The innovative pharmaceutical industry stands ready to contribute through partnerships, innovation, and expertise that support access to quality-assured medicines, vaccines, diagnostics, and health technologies.

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster e.dunster@ifpma.org